4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-016458
Exec. VP, European Commercial sold 991 shares at $11.77 ($11,660)
- Exec. VP, European Commercial acquired 2,098 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Daniell Richard · Exec. VP, European Commercial
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-03 | Exercise or conversion : show line 1 in the form | +2,098 | 10,710 | D | ||
| 2020-03-03 | Sale : show line 2 in the form | −991 | $11.77 | $11,660 | 9,719 | D |
| Open-market sales · 991 sh · avg $11.77 · $11,660 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-03-03 | Exercise or conversion : show line 3 in the form Restricted Share Units | −2,098 | 2,101 | D |
Loading xslF345X03/doc4.xml…